Literature DB >> 8022486

Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells.

B A Witthuhn1, O Silvennoinen, O Miura, K S Lai, C Cwik, E T Liu, J N Ihle.   

Abstract

Many cytokines function through interaction with receptors of the cytokine receptor superfamily. Although lacking catalytic domains, cytokine receptors couple ligand binding to induction of protein tyrosine phosphorylation. Recent studies have shown that one or more of the Janus kinase family members (Jaks) associate with cytokine receptors and are tyrosine phosphorylated and activated following ligand binding. Here we describe a new Jak family kinase, Jak-3, and demonstrate that Jak-3, and to a lesser extent Jak-1, are tyrosine phosphorylated and Jak-3 is activated in the responses to interleukin-2 and interleukin-4 in T cells and myeloid cells. Jak-3 activation requires the serine-rich, membrane-proximal domain of the interleukin-2 receptor beta-chain, but does not require the acidic domain that is required for association and activation of Src family kinases.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8022486     DOI: 10.1038/370153a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  138 in total

1.  A small amphipathic alpha-helical region is required for transcriptional activities and proteasome-dependent turnover of the tyrosine-phosphorylated Stat5.

Authors:  D Wang; R Moriggl; D Stravopodis; N Carpino; J C Marine; S Teglund; J Feng; J N Ihle
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

2.  Differential requirement of the cytoplasmic subregions of gamma c chain in T cell development and function.

Authors:  S Tsujino; J P Di Santo; A Takaoka; T L McKernan; S Noguchi; C Taya; H Yonekawa; T Saito; T Taniguchi; H Fujii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

3.  STAT1 from the cell membrane to the DNA.

Authors:  B F Lillemeier; M Köster; I M Kerr
Journal:  EMBO J       Date:  2001-05-15       Impact factor: 11.598

4.  Identification of p100 as a coactivator for STAT6 that bridges STAT6 with RNA polymerase II.

Authors:  Jie Yang; Saara Aittomäki; Marko Pesu; Kara Carter; Jussi Saarinen; Nisse Kalkkinen; Elliott Kieff; Olli Silvennoinen
Journal:  EMBO J       Date:  2002-09-16       Impact factor: 11.598

Review 5.  Targeting the Jak/STAT pathway for immunosuppression.

Authors:  J J O'shea
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

Review 6.  Biology and significance of the JAK/STAT signalling pathways.

Authors:  Hiu Kiu; Sandra E Nicholson
Journal:  Growth Factors       Date:  2012-02-20       Impact factor: 2.511

7.  Human lymphoid development in the absence of common γ-chain receptor signaling.

Authors:  Lisa A Kohn; Christopher S Seet; Jessica Scholes; Felicia Codrea; Rebecca Chan; Sania Zaidi-Merchant; Yuhua Zhu; Satiro De Oliveira; Neena Kapoor; Ami Shah; Hisham Abdel-Azim; Donald B Kohn; Gay M Crooks
Journal:  J Immunol       Date:  2014-04-25       Impact factor: 5.422

8.  Interleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.

Authors:  K C Gilmour; R Pine; N C Reich
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

9.  The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake.

Authors:  S J Isakoff; C Taha; E Rose; J Marcusohn; A Klip; E Y Skolnik
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).

Authors:  M Nielsen; A Svejgaard; C Röpke; M Nordahl; N Odum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.